Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.550
-0.130 (-3.53%)
Mar 6, 2026, 4:00 PM EST - Market closed

MRVI Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-230.76-259.62-138.38490.66469.25
Depreciation & Amortization
60.4756.8748.7838.133.54
Stock-Based Compensation
30.1749.4234.5918.6710.46
Other Adjustments
90.53173.4283.3933.6231.95
Change in Receivables
12.8214.3684.4-22.27-70.39
Changes in Inventories
80.380.659.46-21.57
Changes in Accounts Payable
-7.350.725.28-1.580.68
Changes in Accrued Expenses
-4.63-23.7415.368.5-3.46
Changes in Unearned Revenue
----7.12-67.85
Changes in Other Operating Activities
-16.82-4.33-7.84-32.07-14.03
Operating Cash Flow
-57.577.47126.22535.98368.57
Operating Cash Flow Growth
--94.09%-76.45%45.42%142.18%
Capital Expenditures
-12.42-22.52-52.69-15.99-14.85
Sale of Property, Plant & Equipment
----0.55
Payments for Business Acquisitions
-18.99--69.62-238.97-
Proceeds from Business Divestments
---0.62119.96
Other Investing Activities
--1.8--13.28-
Investing Cash Flow
-31.41-24.32-122.31-267.61105.66
Long-Term Debt Issued
---8.46-
Long-Term Debt Repaid
-5.44-234.39-5.44-13.9-6
Net Long-Term Debt Issued (Repaid)
-5.44-234.39-5.44-5.44-6
Issuance of Common Stock
---2.36-
Repurchase of Common Stock
----1.71
Net Common Stock Issued (Repurchased)
---2.361.71
Other Financing Activities
-11.06-1.32-55.65-184.42-154.76
Financing Cash Flow
-16.5-235.71-61.09-187.5-159.05
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.03----0.09
Net Cash Flow
-105.51-252.56-57.1880.87315.09
Free Cash Flow
-69.99-15.0573.54519.99353.72
Free Cash Flow Growth
---85.86%47.01%179.00%
FCF Margin
-37.68%-5.81%25.45%58.89%44.26%
Free Cash Flow Per Share
-0.48-0.110.562.041.37
Levered Free Cash Flow
-108.95-371.86-114.93214.0788.49
Unlevered Free Cash Flow
-184.15-226.5616.63510.21402.82
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q